Showing 711-720 of 3024 results for "".
Telestroke & Telecritical Care
https://practicalneurology.com/diseases-diagnoses/imaging-testing/telestroke-telecritical-care/31745/Recent advances in telestroke and telecritical care have improved outcomes, although COVID-19 will have long-lasting effects on these services.Neuromuscular Notes: A Practical Approach to the Diagnosis and Management of Muscle Cramps
https://practicalneurology.com/diseases-diagnoses/neuromuscular/a-practical-approach-to-the-diagnosis-and-management-of-muscle-cramps/36116/Frequent or severe muscle cramps can cause prolonged postcramp soreness and diminish quality of life by disrupting sleep, limiting physical activity, and provoking anxiety about symptom recurrence.Diagnosis and Management of Neurodegenerative Atypical Parkinsonism
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-neurodegenerative-atypical-parkinsonism/30455/- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31264/October 2006 Practical Neurology News Briefs SummarySelecting the appropriate antiepileptic drug (AED) for epilepsy patients remains challenging, with a recent Epilepsia review highlighting that first to third-generation AEDs may lose efficacy over time in a significant subset of patients. The study
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31165/Highlights from the APA Annual Meeting and Recent Neurological AdvancesThe 160th American Psychiatric Association (APA) Annual Meeting in San Diego featured significant discussions and presentations relevant to neurology and psychiatric medicine. Despite protests from over 300 demonstrators, includi
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/30981/Eli Lilly Implements Transparent Physician Payment PolicyEli Lilly has announced a pioneering initiative to enhance transparency in its financial interactions with healthcare professionals. Starting in the latter half of 2009, Lilly will publicly disclose payments exceeding $500 made to physicians f
- When Life Is "Fragrance-Free" — Taste & Smell Disorders In Clinical Neurologyhttps://practicalneurology.com/columns/practice-management/when-life-is-fragrance-free-taste-smell-disorders-in-clinical-neurology/31067/Taste and Smell Disorders: Emerging Concerns in Clinical NeurologyTaste and smell disorders are increasingly recognized within clinical neurology, expanding beyond their traditional focus in otorhino-laryngology. Dr. Ronald Devere underscores the rising prevalence of these sensory impairments in var
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31229/Recent developments in vascular disease management and neurology highlight both challenges and advancements crucial for healthcare professionals. The FDA, in collaboration with Baxter, issued a warning regarding delayed onset heparin-induced thrombocytopenia (HIT) and thrombosis (HITT) associated wi
A Precision Medicine Approach to Dementia Care: Syndrome, Etiology, and Copathology
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-precision-medicine-approach-to-dementia-care-syndrome-etiology-and-copathology/32011/Recognizing multiple neuropathological entities in people with dementia improves understanding of diagnosis, prognosis, and expected outcomes from therapies.Poststroke Recrudescence:
Current Evidence and Considerations for Clinical Practicehttps://practicalneurology.com/diseases-diagnoses/stroke/poststroke-recrudescencebrcurrent-evidence-and-considerations-for-clinical-practice/32073/Despite the high prevalence of recrudescence after stroke and the importance of correct identification of recurrent cerebral ischemia, poststroke recrudescence is poorly understood.